216 related articles for article (PubMed ID: 32253266)
1. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Sojoodi M; Wei L; Erstad DJ; Yamada S; Fujii T; Hirschfield H; Kim RS; Lauwers GY; Lanuti M; Hoshida Y; Tanabe KK; Fuchs BC
Cancer Prev Res (Phila); 2020 Jun; 13(6):497-508. PubMed ID: 32253266
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A.
Tang Y; Cao J; Cai Z; An H; Li Y; Peng Y; Chen N; Luo A; Tao H; Li K
Mol Med Rep; 2020 Nov; 22(5):3873-3885. PubMed ID: 33000276
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of Diethylnitrosamine-Initiated and Phenobarbital-Promoted Hepatocarcinogenesis in Rats by Sulfated Polysaccharides and Aqueous Extract of Ulva lactuca.
Hussein UK; Mahmoud HM; Farrag AG; Bishayee A
Integr Cancer Ther; 2015 Nov; 14(6):525-45. PubMed ID: 26130745
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
Shimizu M; Sakai H; Shirakami Y; Yasuda Y; Kubota M; Terakura D; Baba A; Ohno T; Hara Y; Tanaka T; Moriwaki H
Cancer Prev Res (Phila); 2011 Mar; 4(3):396-403. PubMed ID: 21372039
[TBL] [Abstract][Full Text] [Related]
6. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat.
Matsumoto N; Kohri T; Okushio K; Hara Y
Jpn J Cancer Res; 1996 Oct; 87(10):1034-8. PubMed ID: 8957060
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Kochi T; Shimizu M; Terakura D; Baba A; Ohno T; Kubota M; Shirakami Y; Tsurumi H; Tanaka T; Moriwaki H
Cancer Lett; 2014 Jan; 342(1):60-9. PubMed ID: 23981577
[TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
[TBL] [Abstract][Full Text] [Related]
11. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
12. Targeting increased copper levels in diethylnitrosamine induced hepatocellular carcinoma cells in rats by epigallocatechin-3-gallate.
Farhan M; Rizvi A; Naseem I; Hadi SM; Ahmad A
Tumour Biol; 2015 Nov; 36(11):8861-7. PubMed ID: 26069106
[TBL] [Abstract][Full Text] [Related]
13. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis.
Zhen MC; Wang Q; Huang XH; Cao LQ; Chen XL; Sun K; Liu YJ; Li W; Zhang LJ
J Nutr Biochem; 2007 Dec; 18(12):795-805. PubMed ID: 17481882
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.
Arffa ML; Zapf MA; Kothari AN; Chang V; Gupta GN; Ding X; Al-Gayyar MM; Syn W; Elsherbiny NM; Kuo PC; Mi Z
PLoS One; 2016; 11(12):e0167435. PubMed ID: 27935974
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
[TBL] [Abstract][Full Text] [Related]
16. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells.
Nishida H; Omori M; Fukutomi Y; Ninomiya M; Nishiwaki S; Suganuma M; Moriwaki H; Muto Y
Jpn J Cancer Res; 1994 Mar; 85(3):221-5. PubMed ID: 7514585
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of dieckol on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Sadeeshkumar V; Duraikannu A; Ravichandran S; Fredrick WS; Sivaperumal R; Kodisundaram P
Biomed Pharmacother; 2016 Dec; 84():1810-1819. PubMed ID: 27825803
[TBL] [Abstract][Full Text] [Related]
19. Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats.
Velasco-Loyden G; Pérez-Martínez L; Vidrio-Gómez S; Pérez-Carreón JI; Chagoya de Sánchez V
Tumour Biol; 2017 Feb; 39(2):1010428317691190. PubMed ID: 28231731
[TBL] [Abstract][Full Text] [Related]
20. Regulation of PKB/Akt-pathway in the chemopreventive effect of lactoferrin against diethylnitrosamine-induced hepatocarcinogenesis in rats.
Hegazy RR; Mansour DF; Salama AA; Abdel-Rahman RF; Hassan AM
Pharmacol Rep; 2019 Oct; 71(5):879-891. PubMed ID: 31442665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
